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Participation ofimmune cells in graft rejection, tumor surveillance, resistance
to infection and autoimmunity was demonstrated by classical observations relat-
ing adoptive immunity to cell transfer (1-4) . T lymphocytes are thought to
mediate these processes either by direct cytotoxicity as in allograft rejection, or
by cell-mediated, lymphokine-generated inflammation, as observed in delayed-
type hypersensitivity (DTH)' (5) . Although distinct subpopulations ofT lympho-
cytes may effect these two responses (6) other investigations have suggested that
cytotoxicity may have a role in DTH and thatDTH may contribute to allograft
rejection (7-10) .
Monoclonal antibodies have been used to correlate lymphocyte membrane
antigen expression with human T lymphocyte differentiation (11) . While initial
studies appeared to support a functional classification based upon surface phe-
notype (12), later investigations using cloned progeny of single human and
animal cells also suggested that either cytotoxicity and DTH are not distinct
phenomena, or available monoclonal antibody probes may not distinguish func-
tionally disparate subpopulations ofT lymphocytes (13-15) . Still, in situ immu-
nohistochemical studies of allograft rejection in kidney (16) and skin (17, 18),
sarcoidosis (19), leprosy (20), and graft vs . host disease (21) suggest that under
certain circumstances, T lymphocyte populations are enriched with one or
another identifiable subpopulation .
To further explore the correlation of surface phenotype and cell-mediated
immunity, we studied skin tissues obtained from individuals who manifest DTH
to tuberculin, using monoclonal antibodies reactive with various populations of
mononuclear cells . This prototypic immune response was characterized by early
infiltration of lymphocytes bearing a helper cell marker and monocytes and
subsequently by the expression of cellular antigens associated with activation .
Materials and Methods
Source of Tissue .
￿
12 adult individuals (10 male, 2 female) known to exhibit a delayed
cutaneous response to tuberculin antigens (responders) and 6 unsensitized controls (5
' Abbreviations used in this paper : DTH, delayed-type hypersensitivity ; E-rosette, sheep erythrocyte
rosette ; FITC, fluorescein isothiocyanate ; IL-2, interleukin 2 ; PBS, phosphate-buffered saline, PMN,
polymorphonuclear leukocyte ; TRIC, tetraethylrhodamine isothiocyanate .
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males, 1 female) were studied . All subjects gave informed consent to the protocol that
had been approved by the Committee on the Use of Human Subjects in Research,
University of Minnesota .
Tuberculin-purified protein derivative (Connaught Laboratories, Ontario, Canada) (0 .1
ml) was administered intracutaneously to the 12 responders and 3 controls and a 4-mm
punch biopsy of the innoculation site was performed 6-48 h later . Tuberculin was
administered to one control subject at two sites that were separately biopsied 24 and 48
h later . Three normal skin tissues obtained without prior innoculation of tuberculin were
used as additional controls . Biopsy tissue was snap frozen in precooled isopentane and
stored at -70 ° C until used .
Peripheral venous blood was obtained from nine responders and four controls at the
time of tuberculin administration and at the time of skin biopsy 6-48 hours later .
Monoclonal Antibodies.
￿
Mononuclear cells were identified using the following monoclo-
nal antibodies : TI I (mouse IgG,) (T lymphocytes, Coulter Immunology, Hialeah, FL) ;
OKT3 (IgG2a) (T lymphocytes, Ortho Pharmaceutical, Raritan, NJ) ; OKT4 (IgG2b) (helper
T cells, Ortho) ; OKT8 (IgG2a ) (cytotoxic/suppressor T cells, Ortho); OKMI (IgG2a)
(monocytes and null cells, Ortho) ; Mo2 (IgM) (monocytes, Coulter) ; 63D3 (IgG,) (mono-
cytes, Bethesda Research Laboratories, Inc ., Gaithersburg, MD) ; anti-B1 (IgG 2a ) (B cells,
Coulter) ; Leu-7 (IgM) (large granular lymphocytes, Becton-Dickinson, Mountain View,
CA) ; OKT6 (IgG,) (thymocytes and Langerhans cells, Ortho) OKIal (IgG2 ) (HLA-DR,
Ortho) ; OKT9 (IgG,) (transferrin receptor, Ortho) ; OKTIO (IgG,) (activated T cells,
Ortho) ; and anti-Tac (IgG2a) (interleukin 2 [IL-2] receptor, kindly provided by T .
Waldmann, National Institutes of Health, Bethesda, MD) .
In addition, MBM4, a monoclonal antibody (IgG,) that reacts with Type 4 collagen
(22), was used in concert with certain of the above antibodies as a morphologic probe to
evaluate the relationship of reactive cells to vascular basement membranes . Poly C9-MA,
a monoclonal antibody (IgG,) that reacts with a neoantigen on polymerized C9 of the
membrane attack complex of complement (23) and fluorescein isothiocyanate (FITC)-
labeled goat anti-human C3 were used to search for evidence of complement activation .
Preparation and Staining of Tissue Sections.
￿
Frozen tissue sections (4 km) were prepared
in a Lipshaw cryostat under conditions of constant temperature (22°C) and humidity
(30%), air dried, acetone fixed and washed with phosphate-buffered saline (PBS) pH 7.4 .
Sections were then sequentially reacted with a monoclonal antibody, human plasma
absorbed affinity-isolated FITC F (ab') 2 rabbit anti-mouse IgG (heavy and light chains)
(Zymed Laboratories, Inc ., San Francisco, CA), affinity-isolated FITC F(ab')2 goat anti-
rabbit IgG (heavy and light chains) (Cappel Laboratories, Cochranville PA), ethidium
bromide to stain nuclei, and p-phenylenediamine to retard fluorescence fading (16, 24) .
Some sections were sequentially reacted with two different monoclonal antibodies
followed by the double fluorochrome layer described above or by human plasma-absorbed
FITC F(ab')2 goat antimouse IgM (u) (Cappel) (to detect Leu-7) and human plasma-
absorbed tetraethylrhodamine isothiocyanate (TRIO)-conjugated F(ab') 2 goat anti-mouse
IgG (Fc) (Cappel Laboratories, Cochranville, PA) (to detect T11, OKT8, or OKMI) . In
other studies, tissues were sequentially reacted with mixtures of FITC-labeled TI I
(Coulter) plus anti-Tac or FITC TI1 plus OKIa1 ; followed by rabbit anti-mouse IgG2a
(which binds to anti-Tac or OKIaI but not T11) and then F(ab') 2 TRIC goat anti-rabbit
IgG (heavy and light chains) (Cappel) that had been immunoabsorbed with human plasma
and mouse serum .
Additionally, sections of each tissue were reacted with a mixture ofFITC F(ab') 2 goat
anti-human IgM (u) and FITC F(ab') 2 goat anti-human IgD(b) (Tago, Inc ., Burlingame,
CA) .
Standardization of Monoclonal Antibodies and Controls .
￿
Monoclonal antibodies (except
anti-Tac) were standardized by immunofluorescence using frozen sections of normal
human lymphoid tissue (25-28) . Anti-Tac was standardized as follows : the maximal
dilution without diminished fluorescence of anti-Tac ascites (1 :40,000) was ascertained by
indirect immunofluorescence on frozen tissue sections . Anti-Tac (1 :20,000 and 1 :40,000)
was then absorbed for 1 h with T lymphocytes that had been isolated by sheep erythrocytePLATT ET AL.
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binding (E rosette) and maintained for 4 d in 1 % phytohemagglutinin-leukocyte condi-
tioned medium (29); as a control anti-Tac was absorbed in a similar manner with
unstimulated E rosette-isolated lymphocytes. Frozen sections of three tissues known to
contain numerous anti-Tac binding cells were then reacted with the absorbed anti-Tac
antibodies followed by the double fluorochrome layer as described above. Immunofluo-
rescence was assessed independently by three observers, each of whom was unaware of
which absorbed anti-Tac had been applied to the section .
Control sections of each tissue were prepared as described above, omitting application
of monoclonal antibodies. Other sections were reacted with mouse myeloma proteins of
the same immunoglobulin subclasses as the monoclonal antibodies used in the study
followed by a double fluorochrome layer (16). Additional control sections were reacted
with FITC anti-mouse IgM or TRIC anti-mouse IgG with and without prior applications
of appropriate mouse monoclonal IgG and IgM antibodies (to exclude cross-reactivity of
antisera). Finally, sections of NZB/NZW mouse kidney tissue were sequentially reacted
with rabbit anti-mouse IgG2a, mouse serum absorbed TRIC F(ab')2 goat anti-rabbit and
FITC-labeled T l 1 to exclude binding of T11 by the heteroantisera.
Tissue Analysis.
￿
Sections were examined at 500X with a Zeiss Universal microscope
equipped for epifluorescence and with a 10 mm X 10 mm indexing grid. Reactive cells
(apple-green fluorescent plasma membrane surrounding an ethidium bromide-labeled
orange-red nucleus) and total cells were enumerated in two distinct dermal loci within
each field; (a) mononuclear cell aggregates surrounding vessels; and (b) interstitial dermal
cells apart from aggregates. These data were expressed as the proportion of cells in
aggregates or the proportion of cells in the dermal interstitium reactive with a given
monoclonal antibody. Excluded from cell counts were cells lacking an orange-red nucleus,
fragmented cells and polymorphonuclear cells (PMN) reactive with OKM1 or 63D3 .
Epidermal Langerhans cells reactive with OKT6 were enumerated in a similar fashion
and expressed as reactive cells per 100 basilar epidermal cells.
Blood Cell Analysis. Peripheral blood mononuclear cells were isolated by Ficoll-Hy-
paque gradient reacted with monoclonal antibodies followed by FITC goat anti-mouse Ig
(IgG, IgA, IgM) (Cappel) and quantitated individually by indirect immunofluorescence as
previously described (16). Control suspensions were reacted with mouse ascites in lieu of
monoclonal antibodies or with the fluorochrome alone.
Results
Tissues from responders sensitive to tuberculin contained focal aggregates of
20-400 or more mononuclear cells which surrounded small blood vessels (cap-
illaries or venules) and less numerous infiltrating cells scattered in the interstitial
dermis and epidermis. Within each tissue, the size of aggregates and the number
of scattered infiltrating cells varied with time after injection of the antigen and
with the intensity of the inflammatory response . Epidermal mononuclear cell
infiltration increased with time from inoculation. Numerous PMN (identified by
autofluorescent cytoplasmic granules and characteristic nuclear morphology)
were present in tissues obtained 6 and 12 h after tuberculin administration while
these cells were less frequently observed at later times. Weak granular reactivity
with antihuman C3 and Poly C9-MA was present along the dermal-epidermal
junction of skin and skin appendages and associated with occasional blood vessels
in the dermis.
Composition of Perivascular Mononuclear Cell Aggregates.
￿
Overall 75-90% of
mononuclear cells in perivascular aggregates were identifiable as T lymphocytes
or monocytes, this proportion being greatest in tissues containing the largest
aggregations. There was no distinct relationship between the cellular composition
of perivascular aggregates and time from inoculation of tuberculin or intensity1230 IMMUNE CELL POPULATIONS IN DELAYED-TYPE HYPERSENSITIVITY
of inflammation except that the proportion of T lymphocytes reactive with
OKT4 was greatest at 6 h. The proportion of aggregated mononuclear cells
reactive with each of the monoclonal antibodies is indicated in Table I.
Large aggregates (containing >100 cells) consisted mainly of T lymphocytes
(Tll+, OKT3+) most of which reacted with OKT4 (Fig. 1). OKT8-reactive
cells were less numerous and located in small clusters or scattered within the
aggregate (Fig. 1). Theseaggregatescontained variable proportions ofmonocytes
(OKM1+, 63D3+, Mo2+) located adjacent to capillary walls, at the periphery or
scattered among more numerous Tlymphocytes. The proportionsand locations
of cells reactive with OKM1, 63D3, and Mo2 were generally similar (Tables I
and 11, Fig. 2).
Occasional cells were reactive with anti-B1, with anti-IgD/IgM or with Leu-7.
Clusters of cells reactive with these antibodies were not seen.
Mononuclear Cell Composition ofDermal Interstitium and Epidermis.
￿
Infiltration
of the dermis by T lymphocytes (T11+, OKT3+) and monocytes (OKMI+,
63D3+, Mo2+) increased between 12 and 24 h after tuberculin administration
(Table II). Interstitial cells reactive with OKT4 were more numerous than those
reactive with OKT8 especially at 6 h PPD injection. Cells binding anti-B1, anti-
IgD/IgM, and Leu-7 were infrequently observed.
Epidermal infiltration by T lymphocytes and monocytes increased with dura-
tion of exposure to tuberculin. Cells reactive with OKT8 and OKT4 were
TABLE I
COMPOSITION OF CELLS IN PERIVASCULAR AGGREGATES IN DTH
Mononuclear Cells Reactive with Monoclonal Antibodies by Indirect Immunofluorescence
Percent ofCells in Aggregates
* Affinity-purified F(ab')2 FITC goat anti-human IgD + IgM.
Control tissues from subjects not sensitized to tuberculin.
4 Tissue 5 obtained 15 h after tuberculin administration ; tissue 6, 16 h; tissue 7, 19 h; and tissue 8, 15 h.
Time after to-
berculin
Tll OKT3 OKT4 OKT8 OKMI 63D3 Muy Leu-7 Anti-B1
Anti-IgD/
M*
6h
Tissue
1 46 40 41 11 46 51 43 1.2 1.1 1 .9
2 63 60 48 15 27 30 30 2.4 2.3 2.5
3 63 63 52 11 26 28 31 0.61 2.2 0.96
4# 20 15 14 4.1 24 15 27 2.2 2.9 3.8
15-19 h§
Tissue
5 58 57 44 25 16 17 12 3.5 0.46 1 .1
6 26 23 19 11 31 27 26 2.3 1.0 0.40
7 49 27 36 8.2 37 54 31 3.0 2.7 1 .1
8$ 32 21 9.5 10 27 28 23 0.9 0.48 0.84
24 h
Tissue
9 59 59 29 15 27 30 0.72 1.8 1.1
10 52 53 38 13 40 22 44 2.6 0.50 1 .1
1
1 61 60 44 14 21 20 15 1.2 1.3 0.83
12$ 30 20 21 10 9.9 15 18 0.42 1.0 0.78
48 h
Tissue
13 71 55 51 19 28 29 6.3 1 .9 2.5
14 58 60 37 25 29 20 26 3.3 0.67 0.92
1
5 58 65 46 21 26 25 19 0.63 1.8 2.5
16$ 25 15 20 3.2 21 22 15 1.3 1.9 0.86FIGURE 1 .
￿
T lymphocyte populations in cutaneousdelayed hypersensitivity, identified using
monoclonal antibodies by indirect immunofluorescence in tissues obtained from knownrespon-
ers to tuberculin . (A) T11-reactive cellsform an aggregate around a small blood vessel (V) in
tissue obtained 48 h after tuberculin administration (X 400) ; (B)OKT3-reactive cells in a serial
section of the same aggregate (X 400) ; (C) a large cluster of OKT4-reactive cells surroundsa
blood vessel (V) in tissue obtained at 6 h (x 500) ; (D) OKT8-reactive cells scattered in a
perivascular aggregate in tissue obtained at 6 h(most aggregates in 6-h tissues contained fewer
OKT8-reactive cells) . Several autofluorescent cells (brightly fluorescent cytoplasm) are seen
(x 500) ; (F-) OKT4-reactive cells in an aggregate from tissue obtained at 48 h (x 400) ; (F)
OKT8-reactive cells in an aggregate from tissue obtained at 48 h (x 400) .
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FIGURE 2 .
￿
Monocytes (A andB) and activatedT lymphocytes (C-E) identified in cutaneous
delayed hypersensitivity using monoclonal antibodies by indirect immunofluorescence . Tissues
were obtained at 48 h after tuberculin administration to known responders. (A) OKMI-
reactive cells infiltrating papillary dermis and epidermis (X 450) ; (B) 63133-reactive cells in
papillary dermis and epidermis (X 450) ; (C)mononuclear cells reactive with anti-Tac in a small
dermal perivascular aggregate . A single reactive cell is present in epidermis (X 390) ; (D) A
large perivascular cluster contains some mononuclear cells strongly reactive with anti-Tac. A
population of weakly reactive cells is also seen (X 350) ; (E) Granular OKT9 fluorescence of
many cells forming a perivascular aggregate (X 400) . The patterns of reactivity in C-D were
not observed in 6-h tissues or in control tissues . Arrowheads denote dermal-epidermaljunction
in A-C .
present in this site in approximately equal numbers . Cells binding Leu-7 were
occasionally observed .
Peripheral Blood Cell Populations.
￿
Peripheral blood cell populations in nine
responders and four controls were studied using monoclonal antibodies OKT3,
OKT4, OKT8, OKM1, 63133, and BA-1 6-48 h after tuberculin administration .
The emergence of delayed hypersensitivity was not characterized by specific
changes in the relative proportions ofmononuclear cells in peripheral blood . On
the other hand analysis of ratios of T lymphocyte subpopulations in tissue
compared with blood revealed a relative concentration of OKT4 reactive cells
in tissue from responders during the early course of 13TH (Fig . 3) .
T Lymphocyte Activation.
￿
Evidence of T lymphocyte activation in 13TH was
sought using monoclonal antibodies directed against the transferrin receptor
(OKT9), interleukin 2 receptor (anti-Tac), TIO antigen, and HLA-DR antigen
(OKIal) . In responders the proportion of dermal cells reactive with OKT9,
OKT10, and anti-Tac increased with duration of exposure to tuberculin andTABLE II
COMPOSITION OF DERMAL INTERSTITIAL CELLSIN DTH
Mononuclear Cells Reactive with Monoclonal Antibodies by Indirect Immunofluorescence
Percent ofCells in Interstitium
PLATT ET AL.
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* Affinity-purified F(ab')2 FITC goat anti-human IgD + IgM.
$Control tissues from subjects not sensitized to tuberculin.
Tissue 5 obtained 15 h after tuberculin administration; tissue 6, 16 h; tissue 7, 19 h; and tissue 8,
15 h.
reactivity was particularly noted 48 h after administration oftuberculin (Figs. 2
and 4). Reactive cells were of variable size and were located in the interstitium
and epidermis as well as in aggregates. In contrast, OKIal reacted with few
infiltrating T lymphocytes as described below. Weak granular reactivity of
endothelium with OKT9 accounted for many of the reactive cells observed at 6
and 12 h. The proportion ofT lymphocytes in the epidermis reactive with anti-
Tac appeared to exceed that observed in dermal aggregates. By epifluorescence
phase-contrast microscopy the thin plasma membrane of cells infiltrating the
epidermis and reactive with OKT9, OKT10, and anti-Tac were clearly distin-
guished from keratinocytes and Langerhans cells. Basilar keratinocytes of both
responders and controls reacted weakly with OKT9 at 15, 24, and 48 h. The
reactivity of peripheral blood lymphocytes with OKT10 (nine subjects, two
controls 6-48 h) and with anti-Tac (two subjects, 48 h) was studied by indirect
immunofluorescence as described above. No change in the small proportion
(<2%)of0KT 10 reactive and no anti-Tac reactive peripheral blood lymphocytes
Time
after tu-
berculin
T11 T3 T4 T8 M1 63D3 Mot Leu-7 Anti-B1 Anti-
IgD/M*
TI1 +
OKM1
6h
Tissue
1 9.5 8.5 7.0 2.5 24 19 17 0.25 0.47 1.2 34
2 6.8 8.3 7.7 0.76 18 18 14 0.39 0.89 0.68 25
3 10 10 13 1 .6 19 14 18 0.44 0.51 0.42 29
4$ 4.3 6.9 5.4 3.2 23 20 20 0.68 2.5 1.4 27
15-19h$
Tissue
5 6.5 8.9 5.8 4.6 16 14 13 0.20 0.35 0.84 23
6 4.3 4.2 3.0 3.1 18 13 13 0.17 0.63 1.3 22
7 8.8 9.1 7.5 3.5 20 38 16 0.72 0.68 0.32 29
8$ 3.2 11 4.5 2.4 14 11 13 1.0 0.74 0.50 17
24 h
Tissue
9 26 22 17 9.3 18 22 0.23 0.21 0.29 44
10 11 13 11 7.1 29 15 24 0.50 0.51 0.38 40
11 21 16 13 7.5 20 20 16 0.40 1.0 0.60 41
12t 3.9 2.2 2.4 1.4 7.1 7.1 9.1 0.40 0.12 0.30 11
48 h
Tissue
13 22 19 7.7 6.4 14 19 1.0 1.0 0.91 36
14 29 19 11 10 25 21 18 1.5 0.81 0.60 54
15 35 23 19 8.3 20 21 16 0.11 1.4 1.0 55
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￿
Comparison of T lymphocyte subpopulations identified using monoclonal anti-
bodies by indirect immunofluorescence in tissue andbloodduring course of cutaneousdelayed
hypersensitivity to tuberculin. (A) OKT4/OKT8 ratio of cells in perivascular aggregates vs.
OKT4/OKT8 ratio of peripheral blood at 6, 15-19, 24, and 48 h after tuberculin adminis-
tration to presensitized subjects. (B) OKT4/OKT8 ratio of cells in interstitial dermis apart
from aggregates vs. OKT4/OKT8 ratio in blood. The OKT4/OKTS ratio is increased in all
tissuesat 6 h but not at 15-48 h.
were observed.
The specificity ofanti-Tac for activated T lymphocytes in tissue was suggested
by the following studies: (a) reaction of tissue sections with a mixture of FITC
T11 and anti-Tac (the latter recognized by rabbit anti-mouse IgG2a and mouse
serum absorbed TRIC goat anti-rabbit IgG as described above) revealed that
cells reactive with anti-Tac also reacted with T11 ; (b) tissue binding of anti-Tac
was abrogated by immunoabsorption with activated T lymphocytes but not with
unstimulated T lymphocytes.
Cutaneous Response ofControls.
￿
Control tissues contained perivascular aggre-
gates of mononuclear cells-generally containing 10-50 cells although at least 1
large cluster of >100 cells was observed in each tissue. Substantial infiltration of
the dermal interstitium and epidermis was not seen. The number ofinfiltrating
PMN in control tissues appeared similar to that in responder tissues; however
the proportion of PMN among aggregated cells was greater in controls than in
responders. Weak reactivity with anti-human C3 and Poly C9-MA was present
in a pattern similar to that observed in responders.
The relative proportions ofTlymphocytes, T lymphocyte subpopulations and
monocytes were generally similar to those observed in responders (Tables I and
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FIGURE 4. Expression of T lymphocyte activation antigens identified using monoclonal
antibodies by indirect immunofluorescence during course of cutaneous delayed hypersensitiv-
ity. Proportion of cells in dermal perivascular aggregates reactive with OKT9, OKT10, and
anti-Tac in presensitized subjects (0) and nonresponding controls (Q) was determined at 6,
15-19, 24, and 48 h aftertuberculin administration.
II). However, 6 h after administration oftuberculin, OKT4- and OKT8-reactive
cells were present in almost equal numbers in controls while OKT4-reactive cells
notably exceeded OKT8-reactive cells in responders as described above. Addi-
tionally, the proportion of cells in the dermal interstitium identifiable as T
lymphocytes and monocytes decreased with time after tuberculin injection,
whereas in responders this proportion tended to increase. Study ofcontrol tissues
using OKT9, OKT10, and anti-Tac revealed few reactive cells (Fig. 4).
Reactivity ofTissues with OKT6 and OKIal.
￿
Tissues obtained from responders
and controls were reacted with OKT6, which identifies epidermal Langerhans
cells (30). These cells appeared larger and more reticulated 15-24 h after
tuberculin administration; however, the number of reactive epidermal Langer-
hans cells was similar in responders, controls, and normal skin tissues (Fig. 5).
Occasional cells in mononuclear cell aggregates and in the interstitial dermis
reacted with OKT6.
In all tissues OKIal reacted with fewer Langerhans cells than did OKT6. In
responders and controls up to one-halfof the mononuclear cells in perivascular
aggregates reacted with this antibody. Most of the cells appeared to be mono-
nuclear phagocytes or endothelium. OKIal also reacted with basilar keratino-
cytes ofresponders but not control tissues at 48 h.
Reaction of tissue with TI 1 FITC and OKIa1 (the latter recognized by rabbit
anti-mouse IgG2a and mouse serum and human plasma absorbed F(ab')2 TRIC
goat anti-rabbit) revealed with rare exceptions that the reactive populations did
not overlap.
Identity of Leu-7 Reactive Cells.
￿
Leu-7 reacts with a population of peripheral
blood mononuclear cells that has the capacity to mediate natural killing (31).
Other cell surface antigens expressed by Leu-7-reactive cells were sought using
FITC anti-mouse IgM to identify Leu-7 reactivity and TRIC anti-mouse IgG to
detect binding of T11, OKT8, and OKM1. -50% of Leu-7-reactive cells were
OKT9 OKT10 Anti-Tac
40a
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￿
Epidermal Langerhans cells identified with monoclonal antibody OKT6 by indi-
rect immunofluorescence in cutaneous delayed hypersensitivity to tuberculin expressed as
reactive cellsper 100 basilarepidermal cells. Tissues were obtained from presensitized subjects
(0)and nonrespondingcontrols (O) at 6, 15-19, 24, and 48 h. Results obtained from study of
three skin tissues from normal subjects to whom tuberculin was not administered is shown at
0h.
reactive with T 11, while fewer Leu-7 cells reacted with OKT8 and OKM1. For
example, in tissue 13, these proportions were 53%, 19%, and 37% respectively.
Immunofluorescence Controls. Tissue sections reacted with a double fluoro-
chrome layer alone or with mouse myeloma antibodies in lieu of hybridoma-
derived antibodies did not reveal cell membrane fluorescence. Sections reacted
with Leu-7 (IgM) and TRIC (F(ab')2 goat anti-mouse IgG, or with T11 (IgG)
and FITC F(ab')2 goat anti-mouse IgM were likewise negative. Sections sequen-
tially reacted with FITC T11, rabbit anti-mouse IgG2a, and F(ab')2 TRIC goat
anti-rabbit IgG (human plasma and mouse serum absorbed) revealed only back-
ground rhodamine fluorescence. NZB/NZW mouse kidney tissue controls were
likewise negative. Of peripheral blood lymphocytes treated with PBS or NS-1
ascites in lieu of monoclonal antibodies 0-1.5% were weakly reactive.
Discussion
0) Q 10 `
Delayed-type hypersensitivity is a slowly emerging response by presensitized
subjects to locally administered antigen (32). This study demonstrates that the
cutaneousDTH response to tuberculin is characterized by (a) initialaccumulation
of aggregates of T lymphocytes and monocytes in the vicinity of small blood
vessels; (b) early (6 h) enrichment of OKT4-reactive T lymphocyte populations
in skin in comparison to blood; (c) later (15-48 h) infiltration of the interstitial
dermis and epidermis by T lymphocytes and monocytes; and (d) progressive
expression by infiltrating T lymphocytes of activation antigens recognized by
OKT9, OKT10, and anti-Tac, but not by OKIaI.
Cellular mediation of DTH was first demonstrated by transfer of sensitivity
using unfractionated cells from peritoneal exudates (33, 34) and more recently
by transfer by a single T lymphocyte (15, 35). Since the majority of cells
participating in the reaction are not specifically sensitized (5, 32, 36) these studies
and others (35, 37) suggest an important role for nonspecific inflammation in
initiation of DTH. Furthermore, the development of localized edema whichPLATT ET AL.
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distinguishes an antigen-specific response from nonspecific inflammation is like-
wise generated by nonspecific effector cells such as macrophages and mast cells
(38). Thus in situ analysis may not identify unique antigen-specific cellular
components of DTH. However, prominence of perivascular clusters, early en-
richment of OKT4-reactive lymphocytes, and evidence of T cell activation are
potential morphologic concomitants of antigen-specific recognition.
Antigen recognition and mitogen stimulation areassociated with T lymphocyte
proliferation and expression of cell surface activation antigens (39). Recent
studies have demonstrated that the transferrin (OKT9) and IL-2 (anti-Tac)
receptors are expressed shortly after (6 h) in vitro stimulation ofTlymphocytes,
while expression ofT10 and HLA-DR occur later (40). Analysis ofcell activation
in a process such as DTH is somewhat more difficult since there are potentially
numerous stimuli and varied durations ofactivation. Still, our data demonstrate
that the transferrin and IL-2 receptors are elaborated early in the course of
DTH compared with the delayed and more variable expression of T10 antigen,
and that the display of HLA-DR as manifested by reactivity with OKIaI is not a
requisite feature of this phenomenon.
The mononuclear cell populations that participate in skin graft rejection (17),
cutaneous leprosy (20), and graft vs. host disease (21) have been investigated
using ofmonoclonal antibodies for analysis offrozen tissue sections. In skin graft
rejection and tuberculoid leprosy, most infiltrating Tlymphocytes were reactive
with OKT4, while in lepromatous leprosy and graft vs. host disease most reacted
with OKT8. It is of interest that in allograft rejection both the graft and graft
bed were infiltrated by similar populations of cells (17), and in leprosy and graft
versus host disease monocytes and macrophages were present in abundance (20,
21). These findings suggest either that nonspecific inflammation plays a role in
immune disorders otherthan DTH orthat these disparate processes are mediated
in part at least by DTH.
An analysis of the DTH response to tuberculin using monoclonal antibodies
to identifyTlymphocytes, Tcell subsets, and HLA-DR-bearing cells was recently
reported by Scheynius et al. (41). In contrast to our findings a preponderance of
Leu-3a-reactive cells (analogous to OKT4+) was found at 48 h but not at 6 h,
as in the present report. On the other hand, their observations of balanced
proportions of Leu-2- and Leu-3a-reactive cells at 6 h are consistent with our
findings in small perivascular cell clusters. Thus our study patients may have
exhibited a more rapid or intense DTH response. Poulter et al. (42) studied the
cutaneous DTH response in a similar fashion. They observed dermal infiltration
by T lymphocytes and macrophages, and enumeration of OKT4- and OKT8-
reactive cells yielded results similar to those reported herein. In contrast to our
observations however, OKT8-reactive cells were not seen in the epidermis.
That occasionally substantial numbers ofdermal cells reacted with OKT8 was
not anticipated and their function is not known. They may delimit specific
activity of T4 + lymphocytes, exert cytotoxicity, or mark the contribution of
nonspecific inflammation to DTH. Similarity of proportions of T lymphocyte
populations in established DTH, control tissues, and blood should not imply
functional similarity ofcells in each locale. Rather, these observations underscore
the limitations of in situ analysis of T cell subsets in established DTH.1238 IMMUNE CELL POPULATIONS IN DELAYED-TYPE HYPERSENSITIVITY
Dermal infiltration by monocytes and macrophages was studied using three
monoclonal antibodies. In general these antibodies identified similar proportions
of cells in similar locations in a given tissue. Perivascular aggregates generally
contained fewer cells reactive with these antibodies than with anti-T cell anti-
bodies, while in the dermal interstitium the number of monocytes often equaled
or exceeded that of T lymphocytes. The presence of substantial numbers of
mononuclear phagocytes in DTH are in accord with some prior reports and at
odds with others (32). It may reflect an inflammatory stimulus unrelated to the
antigen-specific response (35, 37).
Langerhans cells of the epidermis are reactive with OKT6 (30) and are
reported to increase in number within 12 h of tuberculin challenge in presensi-
tized individuals (42). However, analysis of this cell population in responder and
control tissues revealed no specific changes associated with emerging cutaneous
DTH. On the other hand enlargement and reticulation of Langerhans cells was
observed in some tissues 12-48 h after inoculation. The apparent discrepancy
may result from methodological differences since only cells sectioned through
the ethidium-bromide stained nucleus were enumerated in our study.
Using a monoclonal antibody directed against the B1 antigen and heteroanti-
sera directed against cell surface immunoglobulins we detected only occasional
B lymphocytes in the tissues studied. While this finding does not exclude
participation of humoral immunity it is consistent with the differential homing
properties of B and T lymphocytes (43). The paucity of infiltrating cells bearing
surface IgM has importance in another context. Despite substantial evidence of
T cell activation, we observed that rare T lymphocytes expressed recognizable
HLA-DR determinants. Since IgM serum antibodies capable of blocking recog-
nition of class II determinants have been detected in tuberculin-challenged
responders (44) our studies could not exclude the possibility that HLA-DR
expression by infiltrating T cells was hidden . However, the absence of significant
numbers of cells with surface IgM, the relatively late (48 h) appearance of HLA-
DR blocking activity in serum (44) and of surface HLA-DR after stimulation (40)
provides substantial evidence that the expression of HLA-DR antigen by T
lymphocytes was not overlooked.
OKIal reacted with basilar keratinocytes in tissues obtained 48 h after tuber-
culin administration in responders but not controls. This pattern of reactivity is
similar to that previously observed in graft vs. host disease in humans (21) and
contact sensitivity in the rat (45). It is of further interest that OKT9 reacted with
basilar keratinocytes as early as 15 h after tuberculin administration, before
notable infiltration of the epidermis occurred. These findings suggest that DTH
influences keratinocyte antigen expression by means other than direct T lym-
phocyte contact.
Prior studies have not suggested a role for complement activation in DTH
(38) yet some deposition of complement components often accompanies inflam-
mation (23). We examined the study tissues using a monoclonal antibody that
identifies the poly C9 component of the membrane attack complex and with
heteroantisera directed against human C3, the presence of which have been
shown to be a highly sensitive indication of Immoral immune injury (23). In these
studies we observed scanty granular reactivity at the dermal epidermal junctionPLATT ET AL.
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(including hair follicles) of all tissues and about eccrine glands. However only
focal endothelial deposits were observed in DTH lesions and the absence of
reactivity amidst large collections of mononuclear cells was striking.
Control tissues contained small perivascular mononuclear cell clusters that
morphologically resembled the smaller clusters in tissues from presensitized
subjects. However, responder tissues obtained 24 and 48 h after tuberculin
administration contained more exuberant infiltration of the dermal interstitium
and epidermis than was observed in any control tissue. Furthermore, early
enrichment of OKT4-reactive cells and activation of substantial numbers of
infiltrating cells was not observed in controls. Despite these differences the
similarity of cell populations in responders and controls is striking and is consist-
ent with prior studies performed by light microscopy (38). This finding inferen-
tially supports aforementioned studies, which have emphasized the role of
nonspecific inflammation in the initiation of DTH.
Summary
Delayed-type hypersensitivity (DTH) is a prototypic T lymphocyte-mediated
response to antigenic challenge. In this study, mononuclear cells infiltrating the
skin during cutaneous response to tuberculin in presensitized human subjects
(responders) and nonimmune controls were identified using monoclonal antibod-
ies by indirect immunofluorescence. In both responders and controls the infil-
trate consisted mainly of T lymphocytes (TI I+ and OKT3+) and monocytes
(OKM1+, 63D3+, Mo2+) which initially accumulated in proximity to small
blood vessels and later infiltrated the interstitial dermis and epidermis. More T
lymphocytes reacted with OKT4 than with OKT8 . 6 h after tuberculin the ratio
of OKT4/OKT8 in tissue from responders exceeded that in blood, whereas in
tissues studied at 15-48 h and in all control tissues those ratios in blood and
tissue were similar. Evidence of T lymphocyte activation was sought using
monoclonal antibodies anti-Tac, OKT9, and OKT10. In responders but not in
controls the proportion of infiltrating cells reactive with these antibodies in-
creased during the course of DTH. The presence of activated T lymphocytes in
tissue was not. associated with a comparable increase in peripheral blood cell
populations identified by anti-Tac and OKT10 . Studies using anti-BI, Leu-7,
and anti-IgD/IgM revealed comparatively few reactive cells. Dual-labeling stud-
ies demonstrated that most Leu-7-reactive cells also bound Tll while fewer
bound OKM1 or OKT8 and that cells reactive with OKIaI and TI I constituted
largely nonoverlapping populations. Specific patterns of reactivity were not
observed when tissues were stained with anti-human C3, or poly C9-MA, a
monoclonal antibody reactive with a neoantigen on polymerized C9 of the
membrane attack complex of complement. The number of epidermal Langer-
hans cells identified by OKT6 was similar in responders and controls. Thus, the
cutaneous response to tuberculin in sensitized individuals is characterized by
early enrichment of the OKT4 subpopulation of T lymphocytes in tissue infil-
trates and subsequent (15-48 h) evidence of T lymphocyte activation.
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